Form4insider filings, from the source

SEC Form 4 · accession 0001171843-16-013526

Protara Therapeutics, Inc. · TARA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Steven Keith Burke
Officer — SVP and Chief Medical Officer
Period of report
Dec 2, 2016
Accepted (ET)
Dec 6, 2016 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 2, 2016G2,500$0.00D30,314D
Common StockF2Dec 2, 2016G2,500$0.00D27,814D
Common StockF3Dec 2, 2016G2,500$0.00D25,314D
Common StockF2Dec 2, 2016G2,500$0.00A2,500ISee footnote
Common StockF3Dec 2, 2016G2,500$0.00A5,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses